Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Applications of modelling studies.

M J Nuijten1, J Starzewski

  • 1Lewin Group, Hoofddorp, The Netherlands. mnuyten@qbnt.quintiles.com

Pharmacoeconomics
|February 6, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toll-like receptors and the tendency of normal mucous membrane to transform to polyp or colorectal cancer.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2009
Same author

Open versus closed laparoscopy entry--which are the evidences?

Hepato-gastroenterology·2009
Same author

Pharmacoeconomics in European decision-making.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
Same author

Do fibrinolytic proteins of human bile derive exclusively from gall bladder?

Medical science monitor : international medical journal of experimental and clinical research·2002
Same author

A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.

PharmacoEconomics·2001
Same author

Assessment of clinical guidelines for continuation treatment in major depression.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2001
Same journal

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

PharmacoEconomics·2026
Same journal

Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

PharmacoEconomics·2026
Same journal

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same journal

A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

PharmacoEconomics·2026
Same journal

Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

PharmacoEconomics·2026
Same journal

Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.

PharmacoEconomics·2026
See all related articles

Economic evaluation and decision-analytical models aid healthcare resource allocation. These models supplement clinical data for reimbursement, program development, and disease management strategies.

Area of Science:

  • Health economics
  • Decision science
  • Health services research

Background:

  • Economic evaluations are crucial for allocating limited healthcare resources.
  • Prospective clinical studies may not provide all necessary economic data.
  • Decision-analytical models offer a solution to bridge information gaps.

Purpose of the Study:

  • To discuss the applications of decision-analytical models in healthcare.
  • To highlight the utility of these models beyond clinical trials.
  • To inform decision-makers on leveraging models for resource allocation.

Main Methods:

  • Review and discussion of various applications of decision-analytical models.
  • Exploration of model use in reimbursement submissions.

Related Experiment Videos

  • Analysis of model integration into pharmacoeconomic development.

    • Main Results:

    • Decision-analytical models support reimbursement authority submissions.
    • Models are valuable for pharmacoeconomic program development.
    • Applications extend to portfolio investment and marketing strategies.

    Conclusions:

    • Decision-analytical models are versatile tools in health services.
    • They enhance resource allocation decisions by providing missing economic information.
    • Model applications span from reimbursement to disease management.